Table 4.
Overall prevalence of CNM in rodents per site in 2012–2014
| 2012 | 2013 | 2014 | Fisher’s exact | ||||
|---|---|---|---|---|---|---|---|
| Site | % (pos/ex) | 95 % CI | % (pos/ex) | 95 % CI | % (pos/ex) | 95 % CI | Testa |
| Bratislava | 4.3 (8/184) | 1.6–7.6 | 16.7 (1/6) | 0.0–50.0 | 0.9 (1/109) | 0.0–2.8 | 0.161 |
| Fúgelka | 9.9 (22/222) | 6.3–14.0 | 50.0 (1/2) | 0.0–100.0 | 9.8 (8/82) | 3.7–17.1 | 1.000 |
| Total | 7.4 (30/406) | 4.9–10.1 | 25.0 (2/8) | 0.0–62.5 | 4.7 (9/191) | 2.1–7.9 | 0.287 |
(pos/ex) number of positive/number of examined, 95 % CI confidence interval
aonly years 2012 and 2014 were compared